We focus on the establishment of SOD2 SNPs (Ala and Val) cell models in LNCaP PCa cells to delineate, in vitro, the mechanism(s) of action of the different allelic variants that may contribute to differential response to MSKE. The gene discussed is SOD2; the disease is posterior cortical atrophy.